Art
J-GLOBAL ID:201802222611488748   Reference number:18A1137714

Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw

ゾレドロン酸とデノスマブの置換は顎の骨壊死を発生させる危険因子である【JST・京大機械翻訳】
Author (8):
Material:
Volume: 125  Issue:Page: 547-551  Publication year: 2018 
JST Material Number: W3379A  ISSN: 2212-4403  Document type: Article
Article type: 原著論文  Country of issue: Netherlands (NLD)  Language: ENGLISH (EN)
Abstract/Point:
Abstract/Point
Japanese summary of the article(about several hundred characters).
All summary is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
Intravenous zoledronic acid (Z...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1137714&from=J-GLOBAL&jstjournalNo=W3379A") }}
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.

Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
, 【Automatic Indexing@JST】
JST classification (2):
JST classification
Category name(code) classified by JST.
Clinical application of other drugs acting on metabolism  ,  Drug therapy(=pharmacotherapy)for tumors 

Return to Previous Page